Eli Lilly (LLY) Stock Pulls Back After String of New Highs

Monday, March 4, 2019 2:10 PM | Brad Spears

Eli Lilly And Co (LLY) stock is higher by 62.86% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives LLY stock a score of 80 out of a possible 100.

That score is chiefly influenced by a short-term technical score of 99. LLY's score also includes a long-term technical score of 99. The fundamental score for LLY stock is 43. In addition to the average rating from Wall Street analysts, LLY stock has a mean target price of $125.63. This means analysts expect the stock to lose 0.72% over the next 12 months.

What's Happening with LLY Stock Today

Eli Lilly And Co (LLY) stock is lower by -1.79% while the S&P 500 is lower by -0.92% as of 1:49 PM on Monday, Mar 4. LLY stock is lower by -$2.30 from the previous closing price of $128.84 on volume of 33,218,483 shares. Over the past year the S&P 500 has risen 2.09% while LLY is higher by 62.86%. LLY stock earned $3.13 a share in the most-recent quarter, giving it a price-to-earnings ratio of 40.52.

Get more analysis and trade ideas on Eli Lilly And Co (LLY) stock.

Related Companies

InvestorsObserver 2020 New Years Resolution Sale

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium

InvestorsObserver Premium

$ 16.58 $ 8.29 /month
$199 $99.50 billed annually

Related Articles

The Dogs Come up a Little Short in 2019

Cronos Group (CRON) Stock: How Does it Score?

Lipocine (LPCN) Stock: What's Next?

Novus Therapeutics (NVUS) Stock Falls -18.6%: How Does it Score?

What's Next for Cronos Group (CRON) Stock?

Endo International (ENDP) Stock Rises 21%: What's Next?

Related Companies